Brought to you by:
Bryan Kay
AI: Where it lands today and how it might impact the vascular future
The speed with which artificial intelligence (AI) is beginning to envelope aspects of the human experience strikes many as jarring. Its entrance into the world of vascular surgery, too, has picked up a pace in recent years, with models and…
Abbott’s Esprit BTK system receives CE mark
Abbott today announced it has received CE mark approval in Europe for the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a technology designed for the treatment of below-the-knee (BTK) peripheral arterial disease (PAD). Abbott notes that the Esprit…
FDA grants approval for IDE study on Advance Evero 18 everolimus-coated balloon catheter
The Food and Drug Administration (FDA) has granted approval for Cook Medical to initiate an investigational device exemption (IDE) study on the Advance Evero 18 everolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter, the company reported today. The clinical study…
Not all carotid procedures are equal after patients suffer a postoperative stroke
Comparative analysis looks at stroke-related disability and mortality after three modes of carotid revascularization. Strokes after transfemoral carotid artery stenting (TFCAS) were “the most disabling and lethal” when compared with transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA) in a…
Aquedeon Medical receives FDA approval to expand clinical trial of Duett vascular graft system
The Food and Drug Administration (FDA) has approved the expansion of Aquedeon Medical’s investigational device exemption (IDE) clinical trial evaluating the Duett vascular graft system, a company press release reveals. Duett is a novel device designed to facilitate open surgical repair…
In wake of President Trump’s chronic venous insufficiency diagnosis, SVS steps up to educate public
News that U.S. President Donald J. Trump has a vascular condition may have simultaneously revealed that a substantial seven-figure vascular surgery branding campaign was starting to yield tangible results, and provided a singular opportunity to platform the specialty as the…
Regional vascular societies gear up for fall annual meetings
The glut of early fall regional vascular society annual meetings is just around the corner, with no fewer than five slated for the month of September. Several have recently made announcements about standout events taking place at their conferences, with…
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year period
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic limb threatening ischemia (CLTI) patients over the past two decades found that they had “significantly improved”…
Early bird pricing deadline for coding workshop falls tomorrow
The early bird pricing deadline for this year’s SVS Coding & Reimbursement Workshop is tomorrow. With significant coding changes going into effect for vascular surgery on Jan. 1, 2026, the Society is urging vascular surgeons, trainees, advanced practice providers (APPs),…
Deadline extended for SVS Foundation grant focused on women’s health
The Society for Vascular Surgery (SVS) Foundation has extended the deadline for a Vascular Care for the Underserved (VC4U) project grant focused on women’s vascular health to Sept. 8. The $20,000 award, in partnership with the SVS Women’s Section, is…